Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients.
Rabia DoğukanRamazan UçakFatih Mert DogukanCanan TanıkBülent ÇitgezFevziye KabukcuoğluPublished in: European journal of breast health (2019)
PD-L1 expression rate was remarkable both in the tumor and the tumor microenvironment of TNBCs. Larger cohorts of TNBC are required to further describe their PD-L1 expression characteristics and help standardize PD-L1 immunohistochemistry assays in these tumors.